Treatment of multicentric Castleman’s disease complicated by the development of non-Hodgkin’s lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support-Reference-Cited by-同舟云学术

Treatment of multicentric Castleman’s disease complicated by the development of non-Hodgkin’s lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support

Published:1999-10 Issue:10 Volume:10 Page:1207-1209
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Advani R.,Rosenberg S.,Warnke R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/10/1207/19477077/10-10-1207.pdf

Reference28 articles.

1. Localized mediastinal lymph node hyperplasia resembling thymoma;Castleman;Cancer,1956

2. Hyaline vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other locations;Keller;Cancer,1972

3. Angiofollicular Lymph Node Hyperplasia (Castleman’s disease);McCarty;Cancer Treat Rev,1985

4. Multicentric Castleman’s disease;Peterson;Semin Oncol,1993

5. Multicentric Angiofollicular lymph node hyperplasia;Weisenberger;A clinicopathologic study of 16 cases. Hum Pathol,1985

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation;American Journal of Hematology;2022-01-19

2. Epigenetic Modifiers and Their Inhibitors in Leukemia Treatment;Epigenetics and Proteomics of Leukemia;2021

3. Overview of Castleman disease;Blood;2020-04-16

4. Castleman’s Disease;Rare Rheumatic Diseases of Immunologic Dysregulation;2018-10-17

5. Treatment of Idiopathic Castleman Disease;Hematology/Oncology Clinics of North America;2018-02